The purpose of this transmittal is to inform District of Columbia (DC) Medicaid Providers that effective January 1, 2020, the Department of Health Care Finance (DHCF) is eliminating the $1.00 co-pay for Medication Assisted Treatment (MAT) drug products used to treat substance use disorders (SUD) for all Fee for Service (FFS) Medicaid beneficiaries.